These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 6442219)
1. [SMON syndrome. First case after abuse of a methylated hydroxyquinoline derivative]. Saragoussi JJ; Soffer M; Giraud D; Raison J; Basdevant A; Pouliquen Y Bull Soc Ophtalmol Fr; 1984 Jan; 84(1):25-8. PubMed ID: 6442219 [No Abstract] [Full Text] [Related]
2. [SMON]. Paal G MMW Munch Med Wochenschr; 1976 Dec; 118(51):suppl [7]-[8]. PubMed ID: 826814 [No Abstract] [Full Text] [Related]
3. Oxyquinoline toxicity. Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067 [No Abstract] [Full Text] [Related]
10. Toxicity of oxyquinolines. Hansson O Lancet; 1977 May; 1(8022):1152. PubMed ID: 68247 [No Abstract] [Full Text] [Related]
11. Ethnic differences in drugs and xenobiotics. Clioquinol. Rose FC Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765 [No Abstract] [Full Text] [Related]
12. More on S.M.O.N. Lancet; 1971 Dec; 2(7736):1244. PubMed ID: 4143604 [No Abstract] [Full Text] [Related]
13. The aetiology of SMON may involve an interaction between clioquinol and environmental metals. Tjälve H Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588 [TBL] [Abstract][Full Text] [Related]
15. [Neuropathy and ocular involvement following prolonged use of tilbroquinol and tiliquinol]. Basdevant A; Soffer M; Saragoussi JJ; Raison J; Pouillon M; Guy-Grand B Rev Med Interne; 1985 Jan; 6(1):65-7. PubMed ID: 3923584 [No Abstract] [Full Text] [Related]